A study to determine the efficacy of Embrace Care device against the currently available solutions in maintaining normal body temperature in low-birth-weight babies in a home setting.
- Conditions
- Health Condition 1: null- CLINICALLY STABLE LOW-BIRTH-WEIGHT (LBW)NEONATES WEIGHING BETWEEN 1500 TO 2000 GRAMS WHO NEED THERMAL SUPPORT.
- Registration Number
- CTRI/2013/02/003439
- Lead Sponsor
- CAMBREE LIFE IMPROVEMENT TECHNOLOGIES PVT LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 100
1)Parental consent for participation
2)Minimum 6 hours of age and not more than 28 days old
3)Not less than 1500 grams and not more than 2000 grams
4)Body temperature not less than 36.0°C
5)Minimum 34 weeks of gestation
6)Mother clinically stable and free from any infection
7)Normal skin conditions
1)External supply of oxygen
2)External supply of intravenous fluids
3)Ongoing treatment for cardiovascular distress characterized by:
•Innocent murmurs particularly if it is nonmusical
•Loud coarse systolic murmur
•Murmur of a ventricular septal defect
•Patent ductus murmur
•Discoloration of the buccal mucous membranes
4)Ongoing treatment for Respiratory distress syndrome characterized by:
oTachypnea
oDyspnea
oSubcostal in drawing
oCyanosis
•Grunting
•Murmurs
5)Ongoing treatment for atelectasis with or without hyaline membrane disease
6)Ongoing treatment for pulmonary haemorrhage
7)Ongoing treatment for intracranial bleeding secondary to anoxia
8)Ongoing treatment for intracranial bleeding secondary to birth trauma
9)Ongoing treatment for pneumonia
10)Ongoing treatment for neonatal sepsis
11)Ongoing treatment for asphyxia at birth
12Ongoing treatment for other infections
13)Ongoing treatment for existing malformations that may adversely affect body temperature
14)Ongoing treatment for jaundice
15)Ongoing treatment for anemia
16)Ongoing treatment of low blood glucose
17)Ongoing treatment for necrotizing enterocolitis
18)Ongoing treatment for intraventricular bleeding
19)Ongoing treatment for metabolic acidosis
20)Ongoing treatment for Retinopathy of Prematurity
21)Ongoing treatment for bleeding diathesis
22)Ongoing treatment for shock
23)Ongoing treatment for hemodynamic instability characterized by:
a.Tachypnea
b.Dyspnea
c.Subcostal indrawing
a.Apnea
b.Requirement for oxygen
c.Convulsions
d.Fever ( >37.50C) or low temperature ( <35.50C)
e.Abnormal state of consciousness
f.Abdominal distension
8)Inadequate breast feeding:
a.Feeding rate less than 8 times in 24 hours
b.Participant does not wet as frequently as feeding
c.Poor attachment and ineffective suckling
d.Participant tires while feeding
e.Mother stops feeding before completion
f.Mother has breast engorgement
g.Mother has sore nipple
24)Ongoing treatment for orthopnea
25)Ongoing treatment for liver enlargement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method